The use of low level laser therapy in the treatment of temporomandibular joint disorders. Review of the literature by Herranz Aparicio, Judit et al.
Med Oral Patol Oral Cir Bucal. 2013 Jul 1;18 (4):e603-12.                                                                                                                                                    LLLT and TMDs. Review of the literature
e603
Journal section: Oral Medicine and Pathology
Publication Types: Review
The use of low level laser therapy in the treatment of temporomandibular 
joint disorders. Review of the literature
Judit Herranz-Aparicio 1, Eduardo Vázquez-Delgado 2, Josep Arnabat-Domínguez 3, Antoni España-Tost 4, 
Cosme Gay-Escoda 5
1 DDS. Fellow of the Master degree program of Oral Surgery and Implantology, School of Dentistry, University of Barcelona
2 DDS.MS. Head of the TMJ and Orofacial Pain Unit of the Master of Oral Surgery and Implantology. University of Barcelona, 
School of Dentistry. Investigator of the IDIBELL Institute. Specialist of the Orofacial Pain Unit of the Teknon Medical Center. 
Barcelona
3 DDS. MD, MS. PhD. �ssociate Professor of Oral Surgery. Co-director of the Master in Lasers in Dentistry. Barcelona Univer-
sity, School of Dentistry. Investigator of the IDIBELL Institute
4 DDS. MD, MS. PhD. �ssociate Professor of Oral Surgery. Professor of the Master of Oral Surgery and Implantology. Direc-
tor of the Master in Lasers in Dentistry. Coordinator of the European Master’s Degree in Oral Laser �pplications (EMDOL�). 
Barcelona University, School of Dentistry. Investigator of the IDIBELL Institute
5 MD, DDS, MS. PhD. Chairman and Professor of Oral and Ma�illofacial Surgery. Director of the Master of Oral Surgery and Im-
plantology. Barcelona University, School of Dentistry. Coordinating/ Investigator of the IDIBELL Institute. Head of the Depart-
ment of Oral and Ma�illofacial Surgery and Coordinator of the Orofacial Pain Unit, Teknon Medical Center. Barcelona, Spain
Correspondence:
Centro Médico Teknon
C/ Vilana 12 
08022 Barcelona, Spain
cgay@ub.edu
Received: 16/09/2012
�ccepted: 15/02/2013
Abstract 
Introduction: The temporomandibular disorders (TMDs) have been identified as the most important cause of pain 
in the facial region. The low level laser therapy (LLLT) has demonstrated to have an analgesic, anti-inflammatory 
and biostimulating effects. The LLLT is a noninvasive, quick and safe, non-pharmaceutical intervention that may 
be beneficial for patients with TMDs. However the clinical efficiency of LLLT in the treatment of this kind of 
disorders is controversial. 
Objectives: Literature review in reference to the use of LLLT in the treatment of TMDs, considering the scientific 
evidence level of the published studies. 
Material and Methods: � MEDLINE and COCHR�NE database search was made for articles. The keywords 
used were “temporomandibular disorders” and “low level laser therapy” or “phototherapy” and by means of the 
Boolean operator “�ND”. The search provided a bank of 35 articles, and 16 relevant articles were selected to this 
review. These articles were critically analyzed and classified according to their level of scientific evidence. This 
analysis produced 3 literature review articles and 13 are clinical trials. The SORT criteria (Strength of Recom-
mendation Ta�onomy) was used to classify the articles. 
Results: Only one article presented an evidence level 1, twelve presented an evidence level 2, and three presented 
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an evidence level 3. According to the principle of evidence-based dentistry, currently there is a scientific evidence 
level B in favor of using LLLT for treatment of TMDs.
Discussion and conclusions: Publications on the use of LLLT for treatment of TMDs are limited making difficult to 
compare the different studies due to the great variability of the studied variables and the selected laser parameters. 
The great majority of the studies concluded that the results should be taken with caution due to the methodological 
limitations.
Key  words: Low level laser therapy; phototherapy; temporomandibular joint disorders.
Introduction
Temporomandibular disorders (TMDs) is a collective 
term that includes disorders of the temporomandibular 
joint (TMJ), and of the masticatory muscles and their as-
sociated structures; characterized by pain, joint sounds, 
and restricted mandibular movement (1,2). TMD etiolo-
gy is currently known to be multifactorial, including the 
presence of parafunctional habits, trauma stress, as well 
as emotional, systemic, hereditary, and occlusal factors 
(2).The etiology is related to an association of predis-
posing factors that increase the risk of TMD, initiating 
factors that cause the onset of TMD, and perpetuating 
factors that interference with healing or enhance TMD 
progression (3). Epidemiological studies show that about 
75% of the population presents one sign of TMD and 35 
% present at least one symptom, however, only a minor 
percentage of the population, 3-7%, presents problems 
severe enough to look for treatment for TMD (4,5).
There is still a lack of consensus on the classification of 
TMD, largely because there is unclear etiology and clin-
ical findings can result from different causes, including 
psychological causes. One commonly used diagnostic 
scheme intended for research purposes is the Research 
Diagnostic Criteria for TMD (RDC/TMD) (6). This 
standardizes the clinical e�amination of patients with 
TMD, improves reproducibility among clinicians, and 
facilitates comparison of results among researchers (7). 
�ggressive and irreversible treatments, such as com-
ple� occlusal therapies and surgeries should be avoided. 
Nonsurgical treatment of TMDs generally consists of 
medication, such as nonsteroidal anti-inflammatory 
drugs (NS�IDs) and antidepressants, splint therapy or/
and physiotherapy. NSAIDs may reduce the inflamma-
tion but may also increase the risk of complications, 
such as gastric ulcer and nephroto�icity. Other treat-
ments used are physical therapy (electrotherapy, ultra-
sound, acupuncture and laser), treatment of parafunc-
tional activities and alternatives therapies. Physical 
therapy is used in the treatment of TMD because of its 
analgesic, myorelaxing, anti-inflammatory and stimula-
tions effects. Low level laser therapy (LLLT) is an op-
tion for the treatment of musculoskeletal disorders, it is 
easy application, limited treatment time and minimum 
contraindications, due to its analgesic, anti-inflammato-
ry and regenerative effects (3,4,8).
The clinical efficacy of LLLT for the treatment of 
TMDs is controversial. Some authors reported best re-
sults comparing the LLLT with a placebo control group, 
while others found no significant differences.
�ccording to some authors there is considerable diver-
sity in the results reported, depending on parameters 
and methodology used. 
The aim of our study is to make a review of the litera-
ture published on the use of LLLT for the treatment of 
TMDs, considering the level of scientific evidence ac-
cording to the principals of evidence-based dentistry. 
Material and Methods
� MEDLINE search was made for articles without re-
striction in year publication. The keywords used were 
“temporomandibular disorders” and “low level laser 
therapy” or “phototherapy” and by means of the Boolean 
operator “AND”. The literature identified was then lim-
ited to studies in humans and articles written in English. 
The same process was used in the COCHR�NE data-
base of the Cochrane Oral Health Group. Two authors 
analyzed the abstracts to verify that the articles obtained 
were pertinent to the topic under study. The irrelevant 
articles were discarded. Ne�t, the same two authors 
independently stratified the scientific articles accord-
ing to their level of scientific evidence using the SORT 
criteria (Strength of Recommendation Ta�onomy). 
Subsequently the authors compared their results; in the 
event of disagreement the results were discussed. If no 
consensus regarding the level of scientific evidence of a 
certain article was possible, a third author was included 
in the discussion. Subsequently, a recommendation was 
given for or against the use of LLLT in the treatment of 
TMD according to the level of scientific evidence of the 
articles analyzed.
Results
The MEDLINE search for TMDs and LLLT or pho-
therapy when were cross provided a bank of 35 articles. 
Ne�t, the abstracts of each article were analyzed to de-
termine if they were pertinent to the topic under study. 
The search in the COCHR�NE database provided 
no relevant articles that agreed with the search crite-
ria of this study. �fter this process 16 relevant articles 
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remained. These articles were critically analyzed and 
classified according to their level of scientific evidence. 
This analysis produced 3 literature review articles and 
13 are clinical trials. 
Description of studies.
1. Bjordal JM, Couppé C, Chow RT, Tunér J, Ljunggren 
E�. Literature systematic review. Evidence level 2. 
2. Medlicott MS, Harris SR. Literature systematic re-
view. Evidence level 2.
3. McNeely ML, �rmijo Olivo S, Magee DJ. Literature 
systematic review. Evidence level 2.
4. De Medeiros JS, Vieira GF, Nishimura PY. Clinical 
trial. Evidence level 3. 
5. Carvalho CM, de Lacerda J�, dos Santos Neto FP, 
Cangussu MC, Marques �M, Pinheiro �L. Clinical 
trial. Evidence level 3. 
6. Fikácková H, Dostálová T, Navrátil L, Klaschka J. 
Clinical trial. Evidence level 2. 
7. Çetiner S, Kahraman SA, Yücetaş S. Evidence level 
2. Clinical trial. Evidence level 2.
8. N�ñez SC, Garcez �S, Suzuki SS, Ribeiro MS. Clin-
ical trial. Evidence level 3. 
9. Venancio Rde �, Camparis CM, Lizarelli RF. Clini-
cal trial. Evidence level 1. 
10. Emshoff R, Bösch R, Pümpel E, Schöning H, Strobl 
H. Clinical trial. Evidence level 2. 
11. Kato MT, Kogawa EM, Santos CN, Conti PCR. 
Clinical trial. Evidence level 2. 
12. Hotta PT, Hotta TH, Bataglion C, Bataglion S�, 
Coronatto E�S, Siesseré S, Regalo SCH. Clinical trial. 
Evidence level 2. 
13. Katsoulis J, �usfeld- Hafter B, Windecker-Gétz I, 
Katsoulis K, Blagojevic N, Mericske-Stern R. clinical 
trial. Evidence level 2. 
14. Mazzetto MO, Hotta TH, Pizzo RC�. Clinical trial. 
Evidence level 2. 
15. Shirani �M, Gutknecht N, Taghizadeh M, Mir M. 
Clinical trial. Evidence level 2. 
16. Kulekcioglu S, Sivrioglu K, Ozcan O, Parlak M. 
Clinical trial. Evidence level 2. 
The results of the clinical trials that study the effects of 
LLLT are summarized in table 1, the results of studies 
that compare LLLT with the use of TENS application 
are summarized in table 2, the results of studies that 
compare LLLT with the use of laser acupuncture are 
summarized in table 3 and the results of laser applica-
tion parameters are summarized in table 4. In accord-
ance with the principals of evidence- based dentistry, the 
analysis produced a level B recommendation strength in 
favor of using LLLT in the treatment of TMDs. Howev-
er, these results should be taken with caution since these 
recommendations are based on studies with important 
methodological defects such as insufficient sample size 
and/or lack of homogeneity among the studied popula-
tions or the laser application parameters. 
Discussion 
Many clinical applications of laser light can be found in 
medicine, dentistry, surgery and many types of lasers in 
different wavelengths have been offered clinicians and 
researchers (9). The use of LLLT has gained much popu-
larity in recent years as a method of management of many 
localized, painful, musculoskeletal conditions (9).
LLLT makes use of the electromagnetic radiation of 
a single wavelength, usually in the red or infrared re-
gions. LLLT provides treatment for several pathologies, 
including impaired wound healing, pain conditions, and 
inflammatory situations (10).
Its basic effects are bio-stimulative, regenerative, anal-
gesic and antinflammatory. It also seems to act on the 
immune, circulatory and haematological systems (3). 
The mechanism of analgesic effect of LLLT is not well 
understood, but according to some reports, LLLT may 
promote analgesic effects via several mechanisms (e.g. 
increases liberation of endogenous opiates, increases 
urinary e�cretion of glucocorticoids, improves local mi-
crocirculation, increases lymphatic flow thus reducing 
edema, decreases permeability of the nerve cell mem-
brane, decreases release of algesic agents in pathologi-
cal sites, increases �TP production, decrease tissue as-
phy�ia and acceleration of wound healing) (3,5,8,11-13). 
Other authors such as Gam et al. (14), suggested that 
there is no scientific evidence to show that laser light 
can penetrate deeper structures, and some studies ques-
tioned the clinical an biological benefits of the physical 
therapy in the treatment of musculoskeletal pain, while 
other authors demonstrate the effectiveness of the low 
level laser therapy for musculoskeletal disorders (2,9).
The importance of investigating the actual analgesic 
efficacy of LLLT lies on the fact that TMD symptoms 
have been treated by a wide array of methods sepa-
rately, such as interocclusal splint, medication, physi-
cal therapy, and transcutaneous electric nerve stimula-
tion; in most cases, however, better outcome is achieved 
when the therapies are associated, where lasers can be 
of great value (12).
LLLT is a noninvasive, quick and safe, non-pharmaceu-
tical intervention that may be beneficial for patients with 
TMJ pain disorders (4,11). Like in any therapy, patients 
respond similarly to LLLT. Patient response depend not 
only on the type of laser, but also on the target tissue 
an immunological system conditions. �n unsatisfactory 
outcome can be due to very low or high dose, incorrect 
diagnosis, small number of sessions, inadequate energy 
density, among others (12).
Publications are scarce on the specific case of using 
LLLT on TMDs. Our research found only 35 which re-
lated the two terms.
The relative clinical efficacy of LLLT for treatment of 
TMD is controversial (4). For most authors, such as 
Kulekcioglu et al. (5) Fikácková et al. (7), Carvalho et 
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al. (8), Çetiner et al. (9), Nuñez et al. (10), Shirani et al. 
(11), Mazzetto et al. (12), Medeiros et al. (13), Kato et al. 
(2) and Hotta et al. (15) demonstrated that LLLT is an ef-
fective therapy for the pain control in subjects with TMD, 
while other studies, like those published by De �breu 
Venancio et al. (3), and Emshoff et al. (4),  presented 
controversial results. Medlicott and Harris and McNeely 
et al. supported that the use of LLLT may improve the 
treatment results of TMD (16,17). Due to utilization of 
different parameters such as wavelength, power, irradia-
tion time, beam area at the skin, energy/energy density, 
number of treatments and interval between treatments 
of laser radiation in various patients groups, the results 
could not have been standardized (4,18).
Light penetration and absorption in biological tissue are 
dependent on several variables, and one of the most im-
portant is the wavelength of the laser.  Different wave-
lengths have been used for treatment of TMDs: 632.8 
nm neon–helium (He–Ne) laser (4), 670 nm (10,13), 690 
nm (19), 780 nm (3,15), 830 nm (2,7,9,12), 890 nm (11), 
wavelengths of 830 nm to 904 nm (2) and 904 nm (5) 
(2). Carvalho et al. (8) used a combination of different 
wavelengths: 660 (red laser) and/or 780 nm, 790 nm or 
830 nm (infrared laser), thinking that the association of 
red and infrared laser light could be effective in pain re-
duction on TMD’s. The same results are were presented 
by Shirani et al. (11) who reported that the combination 
of two wavelength 660 nm (InGa�IP visible red light) 
and 890 nm (infrared laser), were proven to be effective 
treatments for pain reduction in patients with myofas-
cial pain dysfunction syndrome. 
Emshoff et al. (4) used a 632 nm rather than the more 
typical choices of 830 nm or 904 nm. They reported 
that a 632.8 nm wavelength penetrates more deeply into 
musculoskeletal tissues than shorter wavelengths. It was 
also reported a pain reduction with 632 nm compared 
to 820 nm. These results are in accordance with Bros-
seau et al. (20) who reported that here were no statistical 
difference between wavelengths. However, there was a 
trend for improved outcome with the 632nm compared 
to 820 nm for pain although the confidence limits over-
lap [SMD 632 nm: -0.7 (95% CI: -1.2, -0.3) vs SMD 820 
nm: -0.4 (95% CI: -0.8, 0.1)]. 
Concerning the energy density in the different stud-
ies reviewed, it is possible to observe a great diversi-
ty, since that has still not been any definite consensus 
about. De Medeiros et al. (13) recommend an applied 
energy density of 2 J/cm2, Venancio et al. (3) 6•3 J/cm2, 
Authors
and year 
Type of 
study and  
Level of 
Evidence 
Subjects Inclusion and Exclusion Criteria  CG CO Evaluations   Evaluationmethods
Author’s
conclusions 
Nuñez et al. 
2006
Prospective
clinical trial. 
Blinding
techniques?. 
10 Inclusion  
- Limitation of mouth opening due to pain, 
and not having medical or pharmacological 
treatment for TMD in the past 6 months. 
E�clusion 
- Patients with systemic disease. 
No  No  Before and 
immediately 
after therapies 
MVO. Both therapies 
(LLLT and 
TENS) are 
effective in 
improving the 
MVO. LLLT was 
more effective 
than TENS 
therapy. 
Kato et al. 
2006
Prospective
double bind 
clinical trial. 
18 (9 LG 
and 9 
TENS 
group)
Inclusion 
- Individuals presenting signs and 
symptoms of pain on the 
masticatory muscles (temporal and 
masseter).
E�clusion 
- Patients presenting with more than 5 
posterior missing teeth (e�cept for third 
molars) or other occlusal risk factors for 
TMD.
- Subjects with muscle tenderness caused 
by systemic diseases, dental-related pain. 
- Patients with psychological disturbances. 
- �ny restriction for the employment of 
electrical therapy. 
No  No  Immediately 
before and 5 
minutes after 
each session. 
V�S. 
MVO. 
MP. 
Both therapies 
were effective for 
decreasing the 
symptoms of 
patients with 
TMD’s. The 
cumulative effect 
may be 
responsible.
Table 2. Clinical trials with TENS and low level laser application.
CG= control group, CO= Co-treatment, NR= not registered, PG/LG= placebo group/laser group, MVO= ma�imum vertical opening, LE= 
lateral e�cursions, P= protrusion, E�= electrograph  activity, V�S= visual analog scale, LLLT= low level laser therapy, TMD= temporoman-
dibular disorder, VS= verbal scale, MP= muscular palpation, SC= self-care, PPT= pressure pain threshold, DEP= daily e�ercise program, 
NTP= number of tender point, JS= joint sounds.
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Emshoff et al. (4) 1,5 J/cm2,Fickácková et al. (7) 10 or 15 
J/cm2, Carvalho et al. (8) 1-2 J/cm2, Çetiner et al. (9) 7 J/
cm2, Shirani et al. (11) 6.2 J/cm2 and 1 J/cm2, Mazzeto 
et al. (12) 5 J/cm2, Kulekcioglu et al. (5) and Nuñez et 
al. (10) 3  J/cm2, Kato et al. (2) 4 J/cm2 and Hotta et al. 
(15) 35 J/cm2.  The radiation penetration depth is also a 
controversial issue, and more objective data about tissue 
optics is necessary (10). Kulekcioglu et al. (5), suggested 
that infrared laser penetrates deeper than ultraviolet la-
ser, and is most effective between the frequency ranges 
of 700- 1000Hz. 
Further studies are required to establish a radiation time 
and energy dose for significant effects on pathologi-
cal conditions (9). Given the large range of treatment 
parameters involved in this therapy (i.e. wavelength, 
fluence, intensity, exposure time, total duration of the 
treatment), it is not difficult to understand that results 
differ from one study to the ne�t (10). Bjordal et al. (21) 
refers that literature on LLLT is full of conflicting re-
ports, which is caused by the lack dosage consensus, 
suggesting that some poor results in some studies may 
have been caused by insufficient irradiation. 
Kulekcioglu et al. (5) and Çetiner et al. (9), reported a 
reduction of pain and chewing difficulties in myogenic 
TMDs, referring that one month follow-up is a mean-
ingful time to get effective results with LLLT.
Most of the reviewed studies evaluated the patients 
using a V�S (2-5,8,9,11,12,15,19) fact that makes very 
important to remark the psychological component. Pa-
tients with diagnoses of TMDs are rendered suscepti-
ble to placebo effects of any treatment carried out and 
has been shown to be effective in more than 40% of the 
cases (10). The conflicting results may be due too for the 
placebo effects in the treatment period (9), psychologi-
cal factors, such as the desire to feel better, may have 
influenced physiological processes thereby resulting in 
the desired outcome (4). Venancio et al. (3) suggested 
that the power of the placebo effects has been widely 
demonstrated in the treatment of TMDs because a good 
relationship between professional and patient, associ-
Authors and year Wavelength(nm)
Power Output 
(mW)
Total time of each 
session 
(seconds) 
Number of total laser 
sessions/ 
Number of sessions for 
week/ 
Number of weeks 
LLLT clinical trials 
de Medeiros et al. 2005 670 nm 15 mW 858 1/1/1 
Venancio et al. 2005 780 nm 30 mW 10 6/2/3 
Çetiner et al. 2006 830 nm NR 162 100/50/2 
Emshoff et al. 2008 632.8 nm 30 mW 120 20/ 2-3/8 
Shirani et al. 2009 660 nm 17.3 mW ( 0 Hz) 360 6/2/3 (combination of two 
lasers) 890 nm 9.8 W (1,500Hz) 600 
Mazzetto et al. 2010  830 nm 40 mW 10 8/2/4 
Carvalho et al. 2010 660 nm and/or 
780nm,
790 nm or 830 nm 
30-40 mW or 
40-50 mW 
The time of laser 
application was 
automatically set by 
the 
laser units according 
to the dose selected, 
following the 
calibration of the 
manufacturer.
12/NR/6
Fikácková et al. 2007 830 nm 400 mW Not registered 10/not registered/4 
Kulekcioglu et al. 2003 904 nm 17 mW 
(1,000Hz)
180 15/NR/NR
Clinical trials with TENS and LLLT 
Nuñez et al. 2006 670 nm 50 mW 60 1 week 
(1 laser session for week 
and 1 TENS sessions for 
week). 
Kato et al. 2006 830 – 904 nm 100 mW 240 10/3/4 
Clinical trials with acupuncture and LLLT 
Hotta et al. 2010 780 nm 70 mW 20  10/1/10 
Katsoulis et al.  2010 690 nm 40 mW 900 6/2/3 
Table 4. Low level laser technical characteristics.
NR=not registered.
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ated with the appearance of the high technology of the 
laser, might e�plain the V�S reduction for laser and 
placebo groups in clinical control group trials. Kulekci-
oglu et al. (5) reported that pain was significantly im-
proved in the placebo group and this might be e�plained 
in two ways; the placebo effect which is frequently 
encountered when evaluating subjective symptoms in 
similar studies and the indirect influence of daily ex-
ercise program. The literature has associated placebo 
analgesia with 2 potential mechanisms: one sustained 
and engaged for the duration of placebo analgesia, the 
other transitory, that is the feedback mechanism (22). In 
the others parameters, significantly improvements were 
found, only in the laser group. Double blind studies are 
more appropriate when a new therapeutic modality is 
being tested, because the placebo effect seems to be 
very strong, especially in chronic patients (3).
Other or additional way to evaluate the patients is by 
measuring the different jaw movements (3,5,9,10,12,15). 
On the other hand, de Medeiros et al. (13) studied the 
effect of 670 nm on the bite strength of the masseter 
muscle using a gnathodynamometer and observed and 
improvement in muscle contraction strength in all pa-
tients with only one application of 14 minutes. (13) They 
remark that the placebo effect did not affect the meas-
urement of bite strength since it is evaluate before treat-
ment, after placebo lamp session and after laser treat-
ment. The use of this kind of devices, like the algometer, 
is an attempt to quantify pain better, standardizing data 
collection and making their comparison possible (3).
Hotta et al. (15) and Katsoulis et al. (19) studied the effect 
of LLLT in acupuncture points, and they concluded that 
laser acupuncture is a good complementary therapy op-
tion for patients with TMDs. Katsoulis et al. (19) reported 
that the effectiveness of LLLT seems to be comparable to 
that splint therapy; however it is less costly and less time 
consuming. On the other way, Kato et al. (2) and Nuñez 
et al. (10) compared LLLT with the TENS therapy and 
reported a stronger analgesic effect and greater improve-
ment with LLLT than with TENS, but both therapies 
show good results for the treatment of TMDs. 
Few clinical studies, systematic reviews and meta-
analysis investigated the efficacy of the LLLT in other 
musculoskeletal disorders and pain relief. Chow et al. 
(23), in a systematic review, evaluated the efficacy of 
LLLT in the management of neck pain, and concluded 
that the LLLT reduces pain immediately after treatment 
in acute neck pain and up to 22 weeks after completion 
of treatment in patients with chronic neck pain. These 
results are consistent with a double blind, randomized, 
placebo- controlled study published by themselves (24). 
Bjordal et al. (21), in other systematic review, analysed 
the efficacy of LLLT in pain reduction associated in 
chronic joint disorders. They also concluded that LLLT, 
in correct doses, can reduce significantly the pain and 
improve health status in chronic joint disorders. Bros-
seau et al. (20) also made a systematic review about the 
efficacy of LLLT in the treatment of rheumatoid arthri-
tis. It was concluded that LLLT could be considered in 
short-term treatment for pain relief and morning stiff-
ness for rheumatoid arthritis patients, particularly since 
there were few side-effects. Brosseau et al. (20) Bjordal 
et al. (21), and Chow et al. (23), considered that the in-
terpretation of the results should be taken with caution 
because there was heterogeneity in patient samples, 
treatment procedures and trial design, remarking the 
need of further investigations(20,21,23).
Jenkins and Carroll (18), in their report e�plain that 
there is no consensus among manufactures in the way 
they measure and present the specifications of their de-
vices complicating even more this issue. Without some 
standardization the studies are not reproducible, and 
outcomes in clinical research and practice will not be 
consistent. These authors propose a standardized tabu-
lar format, in attempt to provide a standardized method 
for presenting what amount to a quite comprehensive set 
of parameters, and suggest accompanying procedures 
for this and other Journals to follow to ensure compli-
ance by authors (18).
Publications on the use of LLLT for treatment of TMDs 
are limited. � problem detected in this literature re-
viewed is the variation in methodology, dosimetry and 
other parameters between studies, and the inclusion 
criteria and diagnosis of the patients. The studies are 
not standardized and consequently the results differ and 
comparison is difficult. 
�ccording to the principal of evidence-based dentistry, 
there is currently a scientific evidence level B in favor 
of using LLLT for treatment of TMDs. The results pub-
lished in the literature should be analyzed with caution 
since none have sufficient scientific basis, either because 
the sample size is inadequate, or methodological defects 
are present.
We believe that the diagnosis based on the Research Di-
agnostic Criteria for TMD (RCD/TMD) proposed for 
Dworkin and LeReserche (6) and the use of tabular for-
mat proposed for Jenkins and Carroll(18), could stand-
ardize the clinical e�amination for the use of LLLT in 
patients with TMDs, improving reproducibility among 
clinicians, and facilitating comparison of results among 
researchers.  
Furthermore controlled double- blind clinical trials and 
multicentric studies are necessary to demonstrate the 
efficacy of LLLT in TMDs.
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